Necrobiosis Lipoidica Diabeticorum
1 clinical trials · Condition
◉ Watch Necrobiosis Lipoidica Diabeticorum
| Record | Firm | Date |
|---|---|---|
| Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD) (NCT03791060) | Beth Israel Deaconess Medical Center | 2019-04-03 |
Track Necrobiosis Lipoidica Diabeticorum automatically
Every clearance here is in the API, with alerts when new ones post.